The metrics — click any for its citations + threads

Posture med

expanding-but-regulatory-constrained 3 src →

Capital · available high

$93M cumulative VC raised across three tranches (Aug-2024 $30M led by a16z; further close by Jan-2025 bringing cumulative to $40M; Jul-2025 $53M co-led by Radical Ventures + Forerunner … 4 src →

Capital · operating med

no revenue disclosed anywhere found; Ash is a free consumer app (iOS/Android), so no confirmed monetization/operating-revenue figure exists as of this pass 1 src →

Capital · deployed med

capital deployed into: (1) an 18-month model build (proprietary 'foundation model for psychology' trained on real therapist sessions) preceding the Jul-2025 launch, (2) a 50,000-user beta … 2 src →

Capital · in high

pure VC equity, three tranches: a16z-led ($30M, Aug-2024) -> a16z-led extension (cumulative $40M, Jan-2025) -> Radical Ventures + Forerunner Ventures co-led ($53M, Jul-2025, cumulative … 2 src →

Capital · out low

no disclosed multi-year spend commitment or capex figure found; outflows are inferred from the model-build + beta-program + UK launch/withdrawal narrative above, not from any disclosed … 1 src →

Optionality med

constrained 3 src →

Gravity med

~$0.05-0.3B/yr (point estimate ~$0.1B/yr), LOW CONFIDENCE, estimate uncited for scale -- no 2026 active-user, revenue, or clinical-outcome figure was found in any source. The only hard … 3 src →